Canada: Canopy Growth solidifies New Brunswick expansion strategy

Canopy Growth announces that it has acquired Spot Therapeutics, an ACMPR applicant based in Fredericton, New Brunswick. Additionally, through an affiliated entity, the company has entered into a definitive agreement to complete the previously announced purchase of the industrial building and property where the company's Fredericton-based production and distribution platform is being established. These strategic acquisitions solidify Canopy Growth's commitment to expand operations into New Brunswick with a large-scale indoor production facility both quickly, and cost efficiently.

"New Brunswick has emerged as an excellent place to do business in the cannabis sector," said Bruce Linton, Chairman and CEO, Canopy Growth. "We will leverage our existing operational expertise and supplement what the team at Spot has already started so that we can get this facility up and running quickly, supporting local construction and trades to ensure we're making a meaningful contribution to the local economy."

The facility will operate under the Tweed brand and support the company's global operations with high quality, large scale cannabis production capabilities. The existing building and infrastructure is in excellent condition and includes almost 40,000 sq. ft. of dedicated production space. Once licensed, this initial footprint is anticipated to produce over 4,000 kg of dried cannabis annually. With the property appropriately zoned and suited for expansion to over 100,000 sq. ft., this location creates an ideal platform for future growth.

On behalf of Bird Holdings, the current owner of the facility, its President J.W. Bud Bird said, "We are pleased by the sale of our building and impressed with the major expansion initiatives that the new owner, Canopy Growth, has planned for the property. It is great to have an investment of such a magnitude coming to Fredericton's Industrial Park, and it should prove to be an important long-term source of jobs and economic activity for all of central New Brunswick."

Since originally announcing the intent to purchase the facility, Canopy Growth has been working diligently on amendments to the existing application to conform with the company's standardized infrastructure layout and operating procedures. Engineering plans and drawings have already been completed and construction on the facility should begin in October 2017. The facility is anticipated to be ready for licensing and production before the end of 2017.

Brian Neill, CEO of Spot commented, "We have been working for years to bring this new industry to Fredericton, and are proud to be joining forces with Canopy Growth and Tweed as we continue our journey towards an ACMPR license and the launch of a new cannabis platform in the Maritimes."

Under the terms of the transaction, shareholders of Spot will receive up to $2,250,000 in total consideration, less adjustments for all liabilities of Spot as of the closing date and certain payments to be made by Spot between closing and the second tranche payment. At closing, and in satisfaction of the first tranche payment of $1,000,000, Canopy issued 111,669 common shares to the shareholders of Spot. The second tranche payment will be satisfied by the issuance of additional common shares, subject to completion of certain licensing and operational milestones. Closing of the acquisition of the industrial building and property in Fredericton is anticipated to close in early September.

On August 25th, 2017, Canopy Growth received conditional approval from the TSX for the issuance of common shares in connection with this transaction.

For more information:
Canopy Growth
1 Hershey Dr.
Smiths Falls, Ontario
K7A 0A8
1 855 558 9333 x 122
invest@canopygrowth.com
www.canopygrowth.com